A quarter of UK IT professionals not confident with cyber-attack measures
A report released by Infoblox Inc, a network control agency that provides Actionable Network Intelligence, features research into healthcare IT professionals.
The findings, announced 14 November, revealed that one in four healthcare IT professionals in the UK do not feel confident about their organisation’s ability to respond to cyber-attacks.
With the rise of technology becoming incorporated within modern healthcare, the threat of cyber-attacks disrupting services in increasing.
Technologies such as connected medical devices, large data analytics for fast and accurate diagnoses, and paperless systems that aid easily exchanging patient information are putting healthcare at risk.
Cyber-attacks on the healthcare sector could lead to stealing patient data, but could also be as serious as putting lives at risk.
After the disruption of the NHS caused by WannaCry earlier this year in May, many organisations are trying to prepare for ransomware attacks.
One in four participating healthcare IT professionals stated that they would be willing to pay a ransom if in that situation.
Of this quarter, 85% already have a fixed plan of what to do in the event of a cyber-attack.
85% of the professionals when asked announced that their organisation has spent more money on cyber-security in the past year, with 12% increasing spending by at least 50%.
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”